| Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC. (NCT05128630) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2021-10-28 |
| A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab (NCT04302324) | Weill Medical College of Cornell University | 2021-10-28 |
| Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab (NCT05325632) | H. Lee Moffitt Cancer Center and Research Institute | 2021-10-28 |
| Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease (NCT04795466) | Novartis Pharmaceuticals | 2021-10-28 |
| PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) (NCT04550832) | LigaChem Biosciences, Inc. | 2021-10-28 |
| KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent (NCT05001724) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2021-10-28 |
| Firdapse for Post-BOTOX Vocal Weakness (NCT05123053) | Augusta University | 2021-10-28 |
| DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS) (NCT04709705) | Cellphire Therapeutics, Inc. | 2021-10-27 |
| Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms (NCT04141020) | University of Miami | 2021-10-27 |
| Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma (NCT05076786) | Peking Union Medical College Hospital | 2021-10-27 |
| iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT04808791) | AHS Cancer Control Alberta | 2021-10-27 |
| Sustained Release Lidocaine for the Treatment of Postoperative Pain (NCT05193227) | University of British Columbia | 2021-10-27 |
| Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer (NCT05117242) | Genmab | 2021-10-27 |
| PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients (NCT05060471) | Sun Yat-sen University | 2021-10-27 |
| A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors (NCT05091346) | Eisai Inc. | 2021-10-27 |
| A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab (NCT07280377) | Oncolytics Biotech | 2021-10-27 |
| Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma (NCT04989803) | Kite, A Gilead Company | 2021-10-27 |
| MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma (NCT05090566) | Pfizer | 2021-10-27 |
| A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients (NCT05078931) | Shanghai Chest Hospital | 2021-10-27 |
| ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) (NCT04829604) | Ambrx, Inc. | 2021-10-26 |
| Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis (NCT04833894) | argenx | 2021-10-26 |
| Phase 2a MIB-626 vs. Placebo COVID-19 (NCT05038488) | Metro International Biotech, LLC | 2021-10-26 |
| An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy (NCT05055024) | NLS Pharmaceutics | 2021-10-26 |
| A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors. (NCT07392736) | Advenchen Laboratories, LLC | 2021-10-26 |
| A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma (NCT05119335) | NiKang Therapeutics, Inc. | 2021-10-26 |
| Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma (NCT04888611) | Huashan Hospital | 2021-10-26 |
| NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC (NCT04880863) | NeoTX Therapeutics Ltd. | 2021-10-26 |
| BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants Not Receiving Other Complement Inhibitor Therapy (NCT05116787) | BioCryst Pharmaceuticals | 2021-10-26 |
| Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study (NCT05086523) | BackBeat Medical Inc | 2021-10-25 |
| Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial (NCT04259047) | Thomas Jefferson University | 2021-10-25 |
| A Study of Icotinib With Chemotherapy as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer (NCT05104788) | Peking University Cancer Hospital & Institute | 2021-10-25 |
| First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) (NCT05099172) | Bayer | 2021-10-25 |
| A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors (NCT04957290) | Noxopharm Limited | 2021-10-25 |
| HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903 (NCT04975698) | Catherine Bollard | 2021-10-25 |
| A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis (NCT05071664) | Janssen Research & Development, LLC | 2021-10-25 |
| The PREVENT AGITATION Trial II - Children ≤1 Year (NCT05091242) | Rigshospitalet, Denmark | 2021-10-25 |
| Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy (NCT05116813) | Addex Pharma S.A. | 2021-10-25 |
| Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients (NCT05801107) | Qilu Pharmaceutical Co., Ltd. | 2021-10-25 |
| Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients (NCT05033925) | Gadjah Mada University | 2021-10-25 |
| Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided Prostate Biopsy (PROBIOP) (NCT05137561) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-10-25 |
| A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain. (NCT05025787) | Maurizio Fava, MD | 2021-10-25 |
| OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer (NCT04680260) | Karen-Lise Garm Spindler | 2021-10-25 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain (NCT05086289) | Eli Lilly and Company | 2021-10-25 |
| OSU6162 in Bipolar Depression (OBID) (NCT05296356) | Göteborg University | 2021-10-25 |
| Two Step Haplo With Radiation Conditioning (NCT05031897) | Thomas Jefferson University | 2021-10-25 |
| The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer (NCT04927416) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2021-10-25 |
| ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes (NCT04933851) | Scripps Whittier Diabetes Institute | 2021-10-25 |
| Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD) (NCT04304755) | Oslo University Hospital | 2021-10-25 |
| Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan (NCT05025956) | Steadman Philippon Research Institute | 2021-10-24 |
| Propofol Versus Ketamine for Rapid Sequence Intubation in Critically Ill Patients (NCT05092152) | Federal University of São Paulo | 2021-10-23 |
| Safety and Efficacy of MEE-HU Medicus (NCT05023395) | Dr. Ahmed Ismail | 2021-10-23 |
| Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients (NCT04677816) | Wake Forest University Health Sciences | 2021-10-22 |
| Treatment of Occult Inguinal Hernias (NCT04815707) | The University of Texas Health Science Center, Houston | 2021-10-22 |
| A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS) (NCT05168904) | Cyclacel Pharmaceuticals, Inc. | 2021-10-22 |
| Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study (NCT05108974) | Jeff Wozniak | 2021-10-22 |
| MOR202 for Refractory MN (NCT04893096) | Mario Negri Institute for Pharmacological Research | 2021-10-22 |
| Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin (NCT05354817) | Instituto do Cancer do Estado de São Paulo | 2021-10-22 |
| Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis (NCT05055934) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2021-10-22 |
| XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT05005728) | Xencor, Inc. | 2021-10-22 |
| Effect of Dapagliflozin on Submaximal Exercise Tolerance in Heart Failure (NCT04956809) | University of Pennsylvania | 2021-10-22 |
| A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies (NCT05028478) | Curon Biopharmaceutical (Australia) Co Pty Ltd | 2021-10-22 |
| Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection (NCT04267809) | Singapore General Hospital | 2021-10-22 |
| Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer (NCT05052099) | University Hospital, Essen | 2021-10-22 |
| A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine (NCT05067933) | Vaxart | 2021-10-22 |
| To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI (NCT05148403) | Beijing Tiantan Hospital | 2021-10-22 |
| Methylene Blue for the Prevention of Hypotension During Hemodialysis (NCT05092165) | Federal University of São Paulo | 2021-10-21 |
| Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department Discharge (NCT05054023) | University of Monastir | 2021-10-21 |
| Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors (NCT06940349) | Rabin Medical Center | 2021-10-21 |
| Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer (NCT04146298) | Changhai Hospital | 2021-10-21 |
| CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma (NCT05052567) | Qilu Pharmaceutical Co., Ltd. | 2021-10-21 |
| Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS (NCT04708054) | M.D. Anderson Cancer Center | 2021-10-21 |
| Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients (NCT04997941) | Seoul National University Hospital | 2021-10-21 |
| EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers (NCT05176665) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2021-10-21 |
| Osteosarcoma Maintenance Therapy With OST31-164 (NCT04974008) | Emerald Clinical Inc. | 2021-10-21 |
| ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase (NCT05007873) | M.D. Anderson Cancer Center | 2021-10-21 |
| Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis （IPF） (NCT05119972) | Guangdong Raynovent Biotech Co., Ltd | 2021-10-21 |
| Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma (NCT05092217) | Eye & ENT Hospital of Fudan University | 2021-10-20 |
| Study of Acalabrutinib and Tafasitamab in MZL Patients (NCT04646395) | International Extranodal Lymphoma Study Group (IELSG) | 2021-10-20 |
| Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (NCT05101096) | Gilead Sciences | 2021-10-20 |
| A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors (NCT04914286) | Genfleet Therapeutics (Shanghai) Inc. | 2021-10-20 |
| ARX788 in Breast Cancer With Low Expression of HER2 (NCT05018676) | Fudan University | 2021-10-20 |
| A Between Patient Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries (NCT05000983) | University of Manitoba | 2021-10-20 |
| A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC (NCT05044897) | Sichuan Baili Pharmaceutical Co., Ltd. | 2021-10-20 |
| Safety and Efficacy of Sahasthara ME vs Diclofenac ME for Treating Primary Knee Osteoarthritis (NCT06184685) | Thammasat University | 2021-10-20 |
| A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer (NCT04486352) | Alliance Foundation Trials, LLC. | 2021-10-20 |
| A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NCT05091541) | Nanjing IASO Biotechnology Co., Ltd. | 2021-10-20 |
| Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis) (NCT04629144) | Assistance Publique - Hôpitaux de Paris | 2021-10-20 |
| Isothiocyanates and Metabolic Health (NCT05070585) | The Swedish School of Sport and Health Sciences | 2021-10-20 |
| Effectiveness Of High Dose Melatonin As Adjunctive Therapy For Dengue Fever With Warning Signs (NCT05034809) | Ilocos Training and Regional Medical Center | 2021-10-20 |
| Analgesic Effect of Bilateral Erector Spinae Plane Block With Ropivacaine After Sternotomy for Cardiac Surgery (NCT05160298) | University Hospital, Clermont-Ferrand | 2021-10-20 |
| Endothelin-1 Receptor Blockade in Resistant Hypertension (NCT04388124) | University Hospital, Rouen | 2021-10-20 |
| Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM (NCT04891809) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2021-10-20 |
| Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP (NCT05531422) | Lee's Pharmaceutical Limited | 2021-10-20 |
| A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer (NCT05483439) | Shengjing Hospital | 2021-10-20 |
| CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab (NCT05121038) | Anup Kasi | 2021-10-20 |
| Combination Therapy for the Treatment of Diffuse Midline Gliomas (NCT05009992) | University of California, San Francisco | 2021-10-20 |
| A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19. (NCT04880109) | Aptabio Therapeutics, Inc. | 2021-10-20 |
| Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple Sclerosis (NCT04909502) | Emerald Health Pharmaceuticals | 2021-10-19 |
| A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat (NCT05154955) | 10xBio, LLC | 2021-10-19 |
| Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (NCT05041257) | AbbVie | 2021-10-19 |